Biofarm S.A. (BVB:BIO)

Romania flag Romania · Delayed Price · Currency is RON
1.240
-0.020 (-1.59%)
At close: Apr 28, 2026
82.89%
Market Cap 1.22B
Revenue (ttm) 319.33M
Net Income (ttm) 100.63M
Shares Out 985.37M
EPS (ttm) 0.09
PE Ratio 13.46
Forward PE n/a
Dividend 0.04 (3.49%)
Ex-Dividend Date May 13, 2026
Volume 98,683
Average Volume 44,998
Open 1.255
Previous Close 1.260
Day's Range 1.180 - 1.255
52-Week Range 0.632 - 1.355
Beta 0.52
RSI 46.39
Earnings Date May 15, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, medical devices, and other products. The company also exports its products in Albania, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 369
Stock Exchange Bucharest Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

In 2025, Biofarm's revenue was 319.33 million, an increase of 11.36% compared to the previous year's 286.77 million. Earnings were 100.63 million, an increase of 35.27%.

Financial Statements

News

There is no news available yet.